Posted inNews
Lilly’s Alzheimer’s Drug Donanemab Backed by FDA Advisors
Lilly's Alzheimer's Drug Donanemab Backed by FDA Advisors A Food and Drug Administration (FDA) advisory committee has voted in favor of recommending Lilly's Alzheimer's drug donanemab for approval. The vote…